Average Co-Inventor Count = 3.63
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alnylam Pharmaceuticals, Inc. (26 from 445 patents)
2. US Government as Represented by the Secretary of the Army (5 from 8,693 patents)
3. Biogen Idec Ma Inc. (2 from 216 patents)
4. Genentech, Inc. (1 from 3,224 patents)
5. Voyager Therapeutics, Inc. (1 from 41 patents)
6. Jounce Therapeutics, Inc. (1 from 10 patents)
7. Arbutus Biopharma Corporation (57 patents)
30 patents:
1. 11884919 - Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene
2. 11149273 - Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
3. 10983110 - Assays for the detection of AAV neutralizing antibodies
4. 10745704 - Compositions and methods for inhibiting expression of CD274/PD-L1 gene
5. 10669303 - Compositions and methods directed to treating liver fibrosis
6. 10626176 - Methods of treating conditions with antibodies that bind B7-H4
7. 10472628 - Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
8. 9944671 - Compositions and methods directed to treating liver fibrosis
9. 9932593 - Compositions and methods for inhibiting expression of CD274/PD-L1 gene
10. 9868950 - Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
11. 9422562 - Compositions and methods for inhibiting expression of CD274/PD-L1 gene
12. 9206421 - Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
13. 9187516 - Compositions and methods for inhibiting expression of a gene from the Ebola virus
14. 9127275 - Compositions and methods for inhibiting expression of klf-1 and bcl11a genes
15. 9062310 - Compositions and methods for inhibiting expression of factor VII gene